LYRA - Lyra Therapeutics Inc. (LYRA) CEO Maria Palasis on Q4 2020 Results - Earnings Call Transcript
Lyra Therapeutics, Inc. (LYRA) Q4 2020 Earnings Conference Call March 09, 2021 04:30 PM ET Company Participants Laurence Watts - Managing Director, Gilmartin Group Maria Palasis - President & Chief Executive Officer Rob Kern - Chief Medical Officer Don Elsey - Chief Financial Officer Corinne Noyes - Senior Vice President of Commercial Strategy & Market Development Conference Call Participants Chris Howerton - Jefferies Bert Hazlett - BTIG Ash Verma - Bank of America Tim Lugo - William Blair Presentation Operator Welcome to the Lyra Therapeutics Fourth Quarter and End Year 2020 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. Following management's prepare remarks, we will hold a Q&A session. [Operator Instructions] As a reminder, this call is being recorded today March 9, 2021. I would now like to turn the conference call over to Laurence Watts, Managing Director at Gilmartin Group.
For further details see:
Lyra Therapeutics, Inc. (LYRA) CEO Maria Palasis on Q4 2020 Results - Earnings Call Transcript